Approval Year
| Substance Class |
Protein
Created
by
admin
on
Edited
Sat Dec 16 06:22:46 GMT 2023
by
admin
on
Sat Dec 16 06:22:46 GMT 2023
|
| Protein Type | MONOCLONAL ANTIBODY |
| Protein Sub Type | IGG1 |
| Sequence Origin | HUMAN |
| Sequence Type | COMPLETE |
| Record UNII |
4H5YMK1H2E
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WHO-ATC |
J06BB21
Created by
admin on Sat Dec 16 06:22:46 GMT 2023 , Edited by admin on Sat Dec 16 06:22:46 GMT 2023
|
||
|
NCI_THESAURUS |
C20401
Created by
admin on Sat Dec 16 06:22:46 GMT 2023 , Edited by admin on Sat Dec 16 06:22:46 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
SUB127968
Created by
admin on Sat Dec 16 06:22:46 GMT 2023 , Edited by admin on Sat Dec 16 06:22:46 GMT 2023
|
PRIMARY | |||
|
9608
Created by
admin on Sat Dec 16 06:22:46 GMT 2023 , Edited by admin on Sat Dec 16 06:22:46 GMT 2023
|
PRIMARY | |||
|
1855048
Created by
admin on Sat Dec 16 06:22:46 GMT 2023 , Edited by admin on Sat Dec 16 06:22:46 GMT 2023
|
PRIMARY | |||
|
Bezlotoxumab
Created by
admin on Sat Dec 16 06:22:46 GMT 2023 , Edited by admin on Sat Dec 16 06:22:46 GMT 2023
|
PRIMARY | |||
|
4H5YMK1H2E
Created by
admin on Sat Dec 16 06:22:46 GMT 2023 , Edited by admin on Sat Dec 16 06:22:46 GMT 2023
|
PRIMARY | |||
|
Bezlotoxumab
Created by
admin on Sat Dec 16 06:22:46 GMT 2023 , Edited by admin on Sat Dec 16 06:22:46 GMT 2023
|
PRIMARY | |||
|
C153084
Created by
admin on Sat Dec 16 06:22:46 GMT 2023 , Edited by admin on Sat Dec 16 06:22:46 GMT 2023
|
PRIMARY | |||
|
CHEMBL2108670
Created by
admin on Sat Dec 16 06:22:46 GMT 2023 , Edited by admin on Sat Dec 16 06:22:46 GMT 2023
|
PRIMARY | |||
|
1246264-45-8
Created by
admin on Sat Dec 16 06:22:46 GMT 2023 , Edited by admin on Sat Dec 16 06:22:46 GMT 2023
|
PRIMARY | |||
|
DB13140
Created by
admin on Sat Dec 16 06:22:46 GMT 2023 , Edited by admin on Sat Dec 16 06:22:46 GMT 2023
|
PRIMARY | |||
|
YY-53
Created by
admin on Sat Dec 16 06:22:46 GMT 2023 , Edited by admin on Sat Dec 16 06:22:46 GMT 2023
|
PRIMARY | |||
|
DTXSID601028182
Created by
admin on Sat Dec 16 06:22:46 GMT 2023 , Edited by admin on Sat Dec 16 06:22:46 GMT 2023
|
PRIMARY | |||
|
5186
Created by
admin on Sat Dec 16 06:22:46 GMT 2023 , Edited by admin on Sat Dec 16 06:22:46 GMT 2023
|
PRIMARY | |||
|
CHEMBL2109313
Created by
admin on Sat Dec 16 06:22:46 GMT 2023 , Edited by admin on Sat Dec 16 06:22:46 GMT 2023
|
PRIMARY | |||
|
4H5YMK1H2E
Created by
admin on Sat Dec 16 06:22:46 GMT 2023 , Edited by admin on Sat Dec 16 06:22:46 GMT 2023
|
PRIMARY | |||
|
100000153736
Created by
admin on Sat Dec 16 06:22:46 GMT 2023 , Edited by admin on Sat Dec 16 06:22:46 GMT 2023
|
PRIMARY | |||
|
m11977
Created by
admin on Sat Dec 16 06:22:46 GMT 2023 , Edited by admin on Sat Dec 16 06:22:46 GMT 2023
|
PRIMARY |
| From | To |
|---|---|
| 1_22 | 1_96 |
| 1_146 | 1_202 |
| 1_263 | 1_323 |
| 1_369 | 1_427 |
| 2_22 | 2_96 |
| 2_146 | 2_202 |
| 2_263 | 2_323 |
| 2_369 | 2_427 |
| 3_23 | 3_89 |
| 3_135 | 3_195 |
| 4_23 | 4_89 |
| 4_135 | 4_195 |
| 1_222 | 3_215 |
| 2_222 | 4_215 |
| 1_228 | 2_228 |
| 1_231 | 2_231 |
| Glycosylation Link Type | Site |
|---|---|
| N | 1_299 |
| N | 2_299 |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET -> INHIBITOR | |||
|
TARGET ORGANISM->INHIBITOR |
The rate of recurrent C. difficile infection was significantly lower with bezlotoxumab.
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| Molecular Formula | CHEMICAL |
|
||||
| Volume of Distribution | PHARMACOKINETIC |
|
|
|||
| MOL_WEIGHT:NUMBER(CALCULATED) | CHEMICAL |
|
||||
| Biological Half-life | PHARMACOKINETIC |
|
|
|||